HelixTalk - Rosalind Franklin University's College of Pharmacy Podcast (general)

In this episode, we discuss the BRIDGE trial, which investigated whether patients with atrial fibrillation on warfarin need a parenteral anticoagulant "bridge" in preparation and after an elective surgical procedure.

Direct download: 042_-_BRIDGE_trial.mp3
Category:general -- posted at: 6:00am EDT

In this episode, we discuss the 2015-2020 Dietary Guidelines for Americans published by the U.S. Department of Health and Human Services and U.S. Department of Agriculture.

Direct download: 041_-_Dietary_guidelines.mp3
Category:general -- posted at: 6:00am EDT

In this episode, we discuss the many facets of homeopathic medications, including legal status in the United States, safety and efficacy data, and the ethics of homeopathy from the point of view of practicing pharmacists.

Direct download: 040_-_Homeopathic_medicine.mp3
Category:general -- posted at: 6:00am EDT

In this episode, we discuss nausea and vomiting of pregnancy (NVP) with a particular focus on Diclegis (doxylamine/pyridoxine).

Direct download: 039_-_Diclegis_doxylamine-pyridoxine.mp3
Category:general -- posted at: 6:00am EDT

In this episode, we discuss suvarexant (Belsomra), the first dual orexin receptor antagonist approved in the United States for the treatment of insomnia.

Direct download: 038_-_Belsomra_suvarexant.mp3
Category:general -- posted at: 6:00am EDT

In this episode, we have an in-depth review of how to measure glomerular filtration rate (GFR), including variants of the Cockcroft-Gault equation and newer, more accurate methods that may eventually be used to renally adjust certain medications.

Direct download: 037_-_CrCl.mp3
Category:general -- posted at: 6:00am EDT

In this episode, we discuss two agents newly approved for schizophrenia -- Rexulti (brexpiprazole) and cariprazine (Vraylar).

Direct download: 036_-_Two_new_agents_for_schizophrenia.mp3
Category:general -- posted at: 6:00am EDT

In this episode, we discuss two new anti-diabetic medications: empagliflozin (Jardiance) and the EMPA-REG OUTCOME trial as well as dulaglutide (Trulicity), a new GLP1 agonist.

Direct download: 035_-_Empagliflozin_and_dulaglutide.mp3
Category:general -- posted at: 10:03am EDT

In this podcast, we discuss three new injectable insulin formations: Toujeo (insulin glargine U-300), Humalog U-200 (insulin lispro), and Tresiba (insulin degludec).

Direct download: 034_-_New_Injectable_Insulins.mp3
Category:general -- posted at: 6:00am EDT

In this episode, we discuss PCSK9 inhibitors, a new drug class for LDL lowering, with a particular focus on alirocumab (Praluent).

Direct download: 033_-_PCSK9_inhibitors.mp3
Category:general -- posted at: 6:00am EDT